Kotoe Oshima

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun
Shimonagakubo, 4118777, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Journal: International journal of clinical oncology

Published: July 09, 2026

Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations.

Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations.

Journal: Cancers

Published: May 02, 2026

Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

Journal: Japanese journal of clinical oncology

Published: February 20, 2026

Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.

Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.

Journal: The oncologist

Published: January 20, 2026

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Journal: Japanese journal of clinical oncology

Published: August 14, 2025

Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B).

Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B).

Journal: Journal of gastroenterology

Published: June 13, 2025

Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Journal: International journal of clinical oncology

Published: March 19, 2025

Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment.

Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 05, 2025

Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.

Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.

Journal: Gastrointestinal endoscopy

Published: January 24, 2025

Impact of taxanes after PD-1 blockade exposure in advanced esophageal squamous cell carcinoma.

Impact of taxanes after PD-1 blockade exposure in advanced esophageal squamous cell carcinoma.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: June 07, 2024

Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Journal: The oncologist

Published: March 25, 2024

Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.

Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.

Journal: BMC palliative care

Published: December 20, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026